Report me for selling fake medicine? Why are you crying when your illness relapses?

After obtaining the formula for a special liver cancer drug, she immediately became a major contributor to the group, and everything went smoothly.

Clinical trials alone have increased Novartis' market value by billions of dollars.

Of course, market capitalization is just a number, and Novartis's market capitalization often fluctuates, and the range is extremely large.

Sometimes the market drops by two or three hundred billion US dollars a year, and then goes back up again. This is a common occurrence.

It’s just that this time the stock price can directly increase by billions of dollars, which shows that the market has great expectations for the special medicine for liver cancer, which can cause the stock price to soar.

With such a huge contribution, Anna's position in the group has been stabilized.

As long as there is no change, her position as president is almost welded to her ass.

It is even possible that she will inherit the family power and become the real core member in the future.

It can be said that as long as there is no problem with the liver cancer medicine, she can smoothly achieve her long-cherished goal.

It is simply because the liver cancer drug is so important to Novartis that it fills the current vacant business.

Otherwise, it would be the conditions proposed by Chen Xuan.

There was no way Anna would agree so readily.

Now that everything is going so smoothly, her hope of inheriting the group is growing bigger and bigger, which makes her feel that the air is sweet.

Even when she was exercising, the smile on her face never faded.

"Amy, what's the important matter today?" While jogging on the treadmill, Anna did not forget to have a conference call with her assistant and secretary.

Usually before going to work, she would get some latest information from her assistant so that she can handle all matters directly when she gets to work.

At the same time, you can also avoid appearing flustered about some things in front of your subordinates.

Think about how to deal with the problem at home first, and then execute it directly when you return to the company. This way you can remain calm and composed even when faced with a crisis.

This is her habit and also a form of self-restraint.

"Boss An, we just received news from the Huaxia branch."

"They claim that Antai Pharmaceutical Group has developed a new drug and is now preparing to apply for clinical trials."

"At present, we don't know what the new drug is, but it is rumored to be an effective drug for treating cancer. We don't know which type it is." The voice of assistant Amy came.

The fact that she could say this at the first moment proved that she thought it was the most important thing.

Originally, Novartis didn't need to care about the news from a Chinese pharmaceutical company, but this time the situation was special.

Since this matter concerns Chen Xuan, we have to be cautious.

"Antai Pharmaceutical Group?"

"Is this the pharmaceutical company that Chen Xuan has just established?"

Anna obviously thought of this as well.

With her identity, it would be impossible for her to remember the name of a new pharmaceutical company, but this pharmaceutical company was Chen Xuan's company, so she couldn't help but remember it.

In fact, she has been paying attention to the latest news about Chen Xuan. Her sixth sense reminds her all the time that if she can properly tap into a talent like Chen Xuan, she will gain unimaginable benefits.

It’s just that Chen Xuan had not taken any action before, and he didn’t expect that such important news would suddenly be exposed today.

……

……

"Wait, you said he developed a new drug?"

"Is his new drug related to the treatment of liver cancer?" Anna reacted and asked anxiously.

My heartbeat also inexplicably accelerated.

If Chen Xuan really developed other formulas for treating liver cancer, wouldn't the formula in her hand become useless?

"No, we've already investigated."

"Chen Xuan hasn't disclosed the specific applicability of the new drug, but he has publicly stated that it's in a different direction from liver cancer."

"So, we think it could be other types of cancer, but we don't know the specific properties of the drug yet, and it's difficult to pinpoint a specific range of indications."

The female assistant Amy said immediately.